xavier university of louisiana college of pharmacy curriculum map – naplex competencies

11

Xavier University of LouisianaXavier University of LouisianaCollege of PharmacyCollege of Pharmacy

Curriculum Map – NAPLEX CompetenciesCurriculum Map – NAPLEX Competencies

Primary AnalysisPrimary Analysis

Completed by ADPACompleted by ADPA

22

Area 1 - Assure Safe and Effective Pharmacotherapy and Area 1 - Assure Safe and Effective Pharmacotherapy and Optimize Therapeutic OutcomesOptimize Therapeutic Outcomes

1.1.0 – Obtain, interpret and evaluate patient information to determine the presence 1.1.0 – Obtain, interpret and evaluate patient information to determine the presence of a disease or medical condition, assess the need for treatment and/or referral, and of a disease or medical condition, assess the need for treatment and/or referral, and identify patient-specific factors that effect health, pharmacotherapy, and/or disease identify patient-specific factors that effect health, pharmacotherapy, and/or disease managementmanagement

1.1.1 – Identify and assess patient information including medication, laboratory and 1.1.1 – Identify and assess patient information including medication, laboratory and disease state histories.disease state histories.

CBCO Should this competency be introduced in the first year?

Teaching Methods Active learning – 4/6 courses; occurs in the 3Active learning – 4/6 courses; occurs in the 3 rdrd and 4 and 4thth year year

Lecture – 3/6 coursesLecture – 3/6 courses

Other – need to define-3 coursesOther – need to define-3 courses

Assessment Methods

Performance based – 4/6 courses; occurs in the 3Performance based – 4/6 courses; occurs in the 3rdrd and 4 and 4thth yearyear

Test/quiz – 4/6 coursesTest/quiz – 4/6 courses

Other-need to define-1 courseOther-need to define-1 course

33


1.1.0 – Obtain, interpret and evaluate patient information to determine the 1.1.0 – Obtain, interpret and evaluate patient information to determine the presence of a disease or medical condition, assess the need for treatment presence of a disease or medical condition, assess the need for treatment and/or referral, and identify patient-specific factors that effect health, and/or referral, and identify patient-specific factors that effect health, pharmacotherapy, and/or disease managementpharmacotherapy, and/or disease management

1.1.2 – Identify and/or use instruments and techniques related to patient 1.1.2 – Identify and/or use instruments and techniques related to patient assessment and diagnosis.assessment and diagnosis.

CBCOCBCO Should this competency be introduced in the first year?Should this competency be introduced in the first year?

Teaching MethodsTeaching Methods Active Learning – 5/7 courses; occurs in the 2Active Learning – 5/7 courses; occurs in the 2ndnd – 4 – 4thth yearyear


Other-need to define-2 coursesOther-need to define-2 courses

Assessment Assessment MethodsMethods

Performance based – 4/7 courses; occurs in the 3Performance based – 4/7 courses; occurs in the 3rdrd and and 44thth year year


44



1.1.3 – Identify and define the terminology, signs and symptoms 1.1.3 – Identify and define the terminology, signs and symptoms associated with diseases and medical conditions.associated with diseases and medical conditions.

CBCOCBCO Reinforced in the fourth yearReinforced in the fourth year

Teaching MethodsTeaching Methods Active Learning – 4/9 courses; occurs in the 2Active Learning – 4/9 courses; occurs in the 2ndnd – 4 – 4thth yearyear


Other-need to define – 3 coursesOther-need to define – 3 courses

Assessment Assessment MethhodsMethhods

Performance based – 3/9 courses; occurs in the 3Performance based – 3/9 courses; occurs in the 3rdrd and 4and 4thth year year


Other-need to define – 1 courseOther-need to define – 1 course

55



1.1.4 – Identify and evaluate patient factors, genetic factors, biosocial 1.1.4 – Identify and evaluate patient factors, genetic factors, biosocial factors, and concurrent drug therapy that are relevant to the maintenance factors, and concurrent drug therapy that are relevant to the maintenance of wellness and the prevention or treatment of a disease or medical of wellness and the prevention or treatment of a disease or medical condition.condition.

CBCOCBCO Introduced and Reinforced in the 4Introduced and Reinforced in the 4thth year year

Teaching MethodsTeaching Methods Active learning – 4/8 courses; occurs in the 3Active learning – 4/8 courses; occurs in the 3rdrd and 4 and 4thth yearyear




Performance based-4/8; occurs in the 3Performance based-4/8; occurs in the 3rdrd and 4 and 4thth year year

Test/quiz- 6/8 coursesTest/quiz- 6/8 courses


66


1.2.0 – Identify, evaluate, and communicate to the patient or health-care 1.2.0 – Identify, evaluate, and communicate to the patient or health-care provider, the appropriateness of the patient’s specific pharmacotherapeutic provider, the appropriateness of the patient’s specific pharmacotherapeutic agents, dosing regimens, dosage forms, routes of administration, and agents, dosing regimens, dosage forms, routes of administration, and delivery systems.delivery systems.

1.2.1 – Identify specific uses and indications for drug products.1.2.1 – Identify specific uses and indications for drug products.

CBCOCBCO Reinforced in the 4Reinforced in the 4thth year year

Teaching MethodsTeaching Methods Active learning – 4/11 courses; occurs in the 3Active learning – 4/11 courses; occurs in the 3rdrd and 4 and 4thth yearyear




Performance based-4/11 courses; occurs in the 3Performance based-4/11 courses; occurs in the 3rdrd and and 44thth year year

Test/quiz-9/11 coursesTest/quiz-9/11 courses

77



1.2.2 – Identify the known or postulated sites and mechanisms of action of 1.2.2 – Identify the known or postulated sites and mechanisms of action of pharmacotherapeutic agents.pharmacotherapeutic agents.

CBCOCBCO Reinforced in the fourth yearReinforced in the fourth year

Teaching MethodsTeaching Methods Active learning-4/10 courses; occurs in the 3Active learning-4/10 courses; occurs in the 3rdrd and 4 and 4thth yearyear

Lecture-7/10 coursesLecture-7/10 courses



Performance based-5/10 courses; occurs in the 2Performance based-5/10 courses; occurs in the 2ndnd-4-4thth yearyear


88



1.2.3 –Evaluate drug therapy for the presence of pharmacotherapeutic 1.2.3 –Evaluate drug therapy for the presence of pharmacotherapeutic duplications and interactions with other drugs, food, diagnostic tests, and duplications and interactions with other drugs, food, diagnostic tests, and monitoring procedures.monitoring procedures.

CBCOCBCO Introduced in the 3Introduced in the 3rdrd year; reinforced in the 4 year; reinforced in the 4thth year year

Teaching methodsTeaching methods Active learning-5/7 courses; occurs in the 2Active learning-5/7 courses; occurs in the 2ndnd-4-4thth year year




Performance based-4/7 courses; occurs in the 3Performance based-4/7 courses; occurs in the 3rdrd and 4 and 4thth yearyear


99


1.2.0 – Identify, evaluate, and communicate to the patient or health-care 1.2.0 – Identify, evaluate, and communicate to the patient or health-care provider, the appropriateness of the patient’s specific pharmacotherapeutic provider, the appropriateness of the patient’s specific pharmacotherapeutic agents, dosing regimens, dosage forms, routes of administration, and delivery agents, dosing regimens, dosage forms, routes of administration, and delivery systems.systems.

1.2.4 –Identify contraindications, warnings, and precautions associated with a 1.2.4 –Identify contraindications, warnings, and precautions associated with a drug product’s active and inactive ingredients.drug product’s active and inactive ingredients.


Teaching MethodsTeaching Methods Active learning-5/9 courses; occurs in the 2Active learning-5/9 courses; occurs in the 2ndnd - 4 - 4thth year year





Test/quiz-8/9Test/quiz-8/9

1010



1.2.5 –Identify physiochemical properties of drug substances that affect their 1.2.5 –Identify physiochemical properties of drug substances that affect their solubility, pharmacodynamic and pharmacokinetic properties, pharmacologic solubility, pharmacodynamic and pharmacokinetic properties, pharmacologic actions and stability.actions and stability.


Teaching MethodsTeaching Methods Active learning-4/12; occurs in the 3Active learning-4/12; occurs in the 3rdrd and 4 and 4thth year year




Performance based-7/12 courses; occurs in each yearPerformance based-7/12 courses; occurs in each year


1111



1.2.6 – Interpret and apply pharmacodynamic and pharmacokinetic 1.2.6 – Interpret and apply pharmacodynamic and pharmacokinetic principles to calculate and determine appropriate drug dosing regimens.principles to calculate and determine appropriate drug dosing regimens.




Other-need to define;2 coursesOther-need to define;2 courses


Performance based-6/9 courses; occurs in each yearPerformance based-6/9 courses; occurs in each year


1212



1.2.7 – Interpret and apply biopharmaceutic principles and the 1.2.7 – Interpret and apply biopharmaceutic principles and the pharmaceutical characteristics of drug dosage forms and delivery systems, to pharmaceutical characteristics of drug dosage forms and delivery systems, to assure bioavailability and enhance patient compliance.assure bioavailability and enhance patient compliance.


Teaching MethodsTeaching Methods Active learning-4/9 courses; occurs in the 3Active learning-4/9 courses; occurs in the 3rdrd and 4 and 4thth year year




Performance based-5/9 courses; occurs in the 2Performance based-5/9 courses; occurs in the 2ndnd-4-4thth yearyear


1313


1.3.0 –Manage the drug regimen by monitoring and assessing the patient 1.3.0 –Manage the drug regimen by monitoring and assessing the patient and/or patient information, collaborating with other health care professionals, and/or patient information, collaborating with other health care professionals, and providing patient education.and providing patient education.

1.3.1 – Identify pharmacotherapeutic outcomes and endpoints.1.3.1 – Identify pharmacotherapeutic outcomes and endpoints.

CBCOCBCO Introduced in the 3Introduced in the 3rdrd year; Reinforced in the 4 year; Reinforced in the 4thth yearyear

Teaching MethodsTeaching Methods Active learning-4/7 courses; occurs in the 3Active learning-4/7 courses; occurs in the 3rdrd and 4 and 4thth year year






1414


1.3.0 –Manage the drug regimen by monitoring and assessing the 1.3.0 –Manage the drug regimen by monitoring and assessing the patient and/or patient information, collaborating with other health care patient and/or patient information, collaborating with other health care professionals, and providing patient educationprofessionals, and providing patient education..

1.3.2 – Evaluate patient signs and symptoms, and the results of 1.3.2 – Evaluate patient signs and symptoms, and the results of monitoring tests and procedures to determine the safety and monitoring tests and procedures to determine the safety and effectiveness of pharmacotherapy.effectiveness of pharmacotherapy.

CBCOCBCO Introduced in the 3Introduced in the 3rdrd year; Reinforced in the 4 year; Reinforced in the 4thth yearyear

Teaching MethodsTeaching Methods Active learning-4/5 courses; occurs in the 2Active learning-4/5 courses; occurs in the 2ndnd-4-4thth yearyear




Performance based-3/5 courses; occurs in the 3Performance based-3/5 courses; occurs in the 3rdrd and 4and 4thth year year


1515


1.3.0 –Manage the drug regimen by monitoring and assessing the patient 1.3.0 –Manage the drug regimen by monitoring and assessing the patient and/or patient information, collaborating with other health care and/or patient information, collaborating with other health care professionals, and providing patient education.professionals, and providing patient education.

1.3.3 – Identify, describe the mechanism of, and remedy adverse reactions, 1.3.3 – Identify, describe the mechanism of, and remedy adverse reactions, allergies, side effects and iatrogenic or drug-induced illness.allergies, side effects and iatrogenic or drug-induced illness.

CBCOCBCO Introduced in the 3Introduced in the 3rdrd year; reinforced in the 4 year; reinforced in the 4thth yearyear







1616


1.3.0 –Manage the drug regimen by monitoring and assessing the patient 1.3.0 –Manage the drug regimen by monitoring and assessing the patient and/or patient information, collaborating with other health care professionals, and/or patient information, collaborating with other health care professionals, and providing patient education.and providing patient education.

1.3.4 – Prevent, recognize, and remedy medication non-adherence, misuse 1.3.4 – Prevent, recognize, and remedy medication non-adherence, misuse or abuse.or abuse.

CBCOCBCO Introduced in the 3Introduced in the 3rdrd year; reinforced in the 4 year; reinforced in the 4thth year year



Other-need to define-2 courses Other-need to define-2 courses




1717


1.3.0 –Manage the drug regimen by monitoring and assessing the patient 1.3.0 –Manage the drug regimen by monitoring and assessing the patient and/or patient information, collaborating with other health care and/or patient information, collaborating with other health care professionals, and providing patient education.professionals, and providing patient education.

1.3.5 – Recommend pharmacotherapeutic alternatives. 1.3.5 – Recommend pharmacotherapeutic alternatives.

CBCOCBCO Introduced in the 3Introduced in the 3rdrd year; reinforced in the 4 year; reinforced in the 4thth yearyear

Teaching MethodsTeaching Methods Active learning-4/7 courses; occurs in the 2Active learning-4/7 courses; occurs in the 2ndnd-4-4thth year year


Other-need to define- 2 coursesOther-need to define- 2 courses


Performance based-3/7 courses; occurs in the 3Performance based-3/7 courses; occurs in the 3rdrd and and the 4the 4thth year year


1818

Area 2 - Assure Safe and Accurate Preparation Area 2 - Assure Safe and Accurate Preparation and Dispensing of Medicationsand Dispensing of Medications2.1.0 – Perform calculations required to compound, dispense, and 2.1.0 – Perform calculations required to compound, dispense, and administer medication.administer medication.

2.1.1 – Calculate the quantity of medication to be compounded or 2.1.1 – Calculate the quantity of medication to be compounded or dispensed; reduced and enlarge formulation quantities and calculate the dispensed; reduced and enlarge formulation quantities and calculate the quantity of ingredients needed to compound the proper amount of the quantity of ingredients needed to compound the proper amount of the preparation. preparation.

CBCOCBCO Introduced in the 3Introduced in the 3rdrd year; reinforced in the 1 year; reinforced in the 1stst year; this competency is covered in only 3 year; this competency is covered in only 3 coursescourses

Teaching MethodsTeaching Methods Active learning-1/3 courses; occurs in the 3Active learning-1/3 courses; occurs in the 3rdrd year year



Performance based-2/3 courses; occurs in the 2Performance based-2/3 courses; occurs in the 2ndnd and and 33rdrd year year


1919


2.1.2 – Calculate nutritional needs and the caloric content of nutrient 2.1.2 – Calculate nutritional needs and the caloric content of nutrient sources. sources.

CommentsComments This competency is only covered in one courseThis competency is only covered in one course

2020

Area 2 - Assure Safe and Accurate Preparation Area 2 - Assure Safe and Accurate Preparation and Dispensing of Medicationsand Dispensing of Medications2.1.0 – Perform calculations required to compound, dispense, and administer 2.1.0 – Perform calculations required to compound, dispense, and administer medication.medication.

2.1.3 – Calculate the rate of drug administration. 2.1.3 – Calculate the rate of drug administration.

CBCOCBCO Appears to be okay.Appears to be okay.



Assessment Assessment MethhodsMethhods

Performance based-1/4 courses; occurs in the 3Performance based-1/4 courses; occurs in the 3rdrd year year


2121


2.1.4 – Calculate or convert drug concentrations, ratio strengths, and/or 2.1.4 – Calculate or convert drug concentrations, ratio strengths, and/or extent of ionization. extent of ionization.

CBCOCBCO Appears to be okay.Appears to be okay.




Performance based-2/4 courses; occurs in the 2Performance based-2/4 courses; occurs in the 2ndnd and and 33rdrd year year


2222

Area 2 - Assure Safe and Accurate Preparation Area 2 - Assure Safe and Accurate Preparation and Dispensing of Medicationsand Dispensing of Medications

2.2.0 – Select and dispense medications in a manner that promotes safe 2.2.0 – Select and dispense medications in a manner that promotes safe and effective use.and effective use.

2.2.1 – Identify drug products by their generic, brand, and/or common 2.2.1 – Identify drug products by their generic, brand, and/or common names. names.

CBCO Reinforced in the fourth year

Teaching Methods Active learning-2/9 courses; occurs in the 3rd and 4th year

Lecture-5/9 courses

Other-need to define-2 courses

Assessment Methods

Performance based-2/9 courses; occurs in the 3rd and 4th year

Test/quiz – 8/9 courses

2323

Area 2 - Assure Safe and Accurate Preparation Area 2 - Assure Safe and Accurate Preparation and Dispensing of Medicationsand Dispensing of Medications2.2.0 – Select and dispense medications in a manner that promotes safe 2.2.0 – Select and dispense medications in a manner that promotes safe and effective use.and effective use.

2.2.2 – Determine whether a particular drug dosage strength or dosage 2.2.2 – Determine whether a particular drug dosage strength or dosage form is commercially available, and whether it is available on a form is commercially available, and whether it is available on a nonprescription basis. nonprescription basis.

CBCO Introduced in the 4th year

Teaching Methods Active learning-2/7 courses; occurs in the 3rd and 4th year

Lecture-4/7 courses

Other-need to define-2 courses

Assessment Methods

Performance based-2/7 courses; occurs in the 3rd and 4th year

Test/quiz-3/7 courses

Other-need to define-1 course

2424


2.2.0 – Select and dispense medications in a manner that promotes safe 2.2.0 – Select and dispense medications in a manner that promotes safe and effective use.and effective use.

2.2.3 – Identify commercially available drug products by their characteristic 2.2.3 – Identify commercially available drug products by their characteristic physical attributes. physical attributes.

CBCOCBCO This competency is only covered in 1 course.This competency is only covered in 1 course.

2525


2.2.4– Interpret and apply pharmacokinetic parameters and quality 2.2.4– Interpret and apply pharmacokinetic parameters and quality assurance data to determine equivalence among manufactured drug assurance data to determine equivalence among manufactured drug products, and identify products for which documented evidence of products, and identify products for which documented evidence of inequivalence exists. inequivalence exists.

CBCOCBCO Appears to be okayAppears to be okay





Performance based – 0/4 coursesPerformance based – 0/4 courses



2626


2.2.5 – Identify and communicate appropriate information regarding 2.2.5 – Identify and communicate appropriate information regarding packaging, storage, handling, administration, and disposal of packaging, storage, handling, administration, and disposal of medications. medications.

CBCOCBCO Introduced in the 3Introduced in the 3rdrd and 4 and 4thth year year





Performance based-1/7 courses; occurs in the 4Performance based-1/7 courses; occurs in the 4thth yearyear



2727


2.2.6 – Identify and describe the use of equipment and apparatus 2.2.6 – Identify and describe the use of equipment and apparatus required to administer medications. required to administer medications.

CBCOCBCO Introduced in the 3Introduced in the 3rdrd year; this competency is year; this competency is not reinforcednot reinforced

Teaching MethodsTeaching Methods Active learning – 3/6 courses; occurs in the 3Active learning – 3/6 courses; occurs in the 3rdrd and and 44thth year year




Performance based-1/6 courses; occurs in the 3Performance based-1/6 courses; occurs in the 3rdrd yearyear



2828

Area 2 - Assure Safe and Accurate Preparation Area 2 - Assure Safe and Accurate Preparation and Dispensing of Medicationsand Dispensing of Medications2.3.0 – Prepare and compound extemporaneous preparations and 2.3.0 – Prepare and compound extemporaneous preparations and sterile products.sterile products.

2.3.1 – Identify and describe techniques and procedures related to 2.3.1 – Identify and describe techniques and procedures related to drug preparation, compounding and quality assurance.drug preparation, compounding and quality assurance.

CBCOCBCO Introduced in the 3Introduced in the 3rdrd year year




Performance based-1/4 courses; occurs in the 2Performance based-1/4 courses; occurs in the 2ndnd yearyear


2929

Area 2 - Assure Safe and Accurate Preparation Area 2 - Assure Safe and Accurate Preparation and Dispensing of Medicationsand Dispensing of Medications2.3.0 – Prepare and compound extemporaneous preparations and sterile 2.3.0 – Prepare and compound extemporaneous preparations and sterile products.products.

2.3.2 – Identify and use equipment necessary to prepare and 2.3.2 – Identify and use equipment necessary to prepare and extemporaneously compound medications.extemporaneously compound medications.

CBCOCBCO Introduced in the 3Introduced in the 3rdrd year; this competency is year; this competency is not reinforcednot reinforced



Assessment MethodsAssessment Methods Performance based-1/3 courses; occurs in the 2Performance based-1/3 courses; occurs in the 2ndnd yearyear


3030


2.3.0 – Prepare and compound extemporaneous preparations and sterile 2.3.0 – Prepare and compound extemporaneous preparations and sterile products.products.

2.3.3 – Identify the important physiochemical properties of a preparation’s 2.3.3 – Identify the important physiochemical properties of a preparation’s active and inactive ingredients; describe the mechanism of, and the active and inactive ingredients; describe the mechanism of, and the characteristic evidence of incompatibility or degradation; and identify characteristic evidence of incompatibility or degradation; and identify methods for achieving stabilization of the preparationmethods for achieving stabilization of the preparation

CBCOCBCO Introduced in the 3Introduced in the 3rdrd year; this competency is year; this competency is not emphasizednot emphasized

Teaching methodsTeaching methods Active learning-1/7 courses; occurs in the 3Active learning-1/7 courses; occurs in the 3rdrd year year



Performance based-2/7 courses; occurs in the 2Performance based-2/7 courses; occurs in the 2ndnd yearyear


3131

Area 3 - Provide Health Care Information and Area 3 - Provide Health Care Information and Promote Public HealthPromote Public Health3.1.0 – Access, evaluate, and apply information to promote optimal health 3.1.0 – Access, evaluate, and apply information to promote optimal health care.care.

3.1.1 – Identify the typical content and organization of specific sources of 3.1.1 – Identify the typical content and organization of specific sources of drug and health information for both health care providers and consumers.drug and health information for both health care providers and consumers.

CBCOCBCO Introduced and reinforced in the 4Introduced and reinforced in the 4thth year; year; introduced in the 3introduced in the 3rdrd year year

Teaching MethodsTeaching Methods Active learning-3/3 courses; occurs in the 1Active learning-3/3 courses; occurs in the 1stst, 3, 3rdrd, and 4, and 4thth yearyear




Performance based-3/3 courses; occurs in the 1Performance based-3/3 courses; occurs in the 1stst, 3, 3rdrd, , and 4and 4thth year year



3232

Area 3 - Provide Health Care Information and Area 3 - Provide Health Care Information and Promote Public HealthPromote Public Health3.1.0 – Access, evaluate, and apply information to promote optimal health care.3.1.0 – Access, evaluate, and apply information to promote optimal health care.

3.1.2 – Evaluate the suitability, accuracy, and reliability of information from 3.1.2 – Evaluate the suitability, accuracy, and reliability of information from reference sources by explaining and evaluating the adequacy of experimental reference sources by explaining and evaluating the adequacy of experimental design and by applying and evaluating statistical test and parameters.design and by applying and evaluating statistical test and parameters.

CourseCourse CBCOCBCO Teaching Teaching method(s)method(s)

Assessment Assessment method(s)method(s)

PSL – IPSL – I II O, SGD, LO, SGD, L IGP, HW, OP, P, IGP, HW, OP, P, RPRP

BiopharmaceuticsBiopharmaceutics RR LL TT

IPPE – IIIIPPE – III II SGDSGD RP, OP, IGPRP, OP, IGP

Clinical RotationClinical Rotation R, ER, E O, CS, SGDO, CS, SGD O, OPO, OP

3333

Area 3 - Provide Health Care Information and Area 3 - Provide Health Care Information and Promote Public HealthPromote Public Health3.2.0 – Educate the public and health care professionals regarding medical 3.2.0 – Educate the public and health care professionals regarding medical conditions, wellness, dietary supplements, and medical devices.conditions, wellness, dietary supplements, and medical devices.

3.2.1 – Provide health care information regarding the prevention and treatment 3.2.1 – Provide health care information regarding the prevention and treatment of diseases and medical conditions, including emergency patient care.of diseases and medical conditions, including emergency patient care.



Pharmacy LawPharmacy Law RR LL TT

IPPE – IIIIPPE – III II SGDSGD IGPIGP

Clinical RotationClinical Rotation R, ER, E O, SGDO, SGD D, HW, OPD, HW, OP

3434


3.2.2 – Provide health care information regarding nutrition, lifestyle, and other 3.2.2 – Provide health care information regarding nutrition, lifestyle, and other non-drug measures that are effective in promoting health or preventing or non-drug measures that are effective in promoting health or preventing or minimizing the progression of a disease or medical condition.minimizing the progression of a disease or medical condition.



BiochemistryBiochemistry II LL TT

Pharmacy Pharmacy PracticePractice

RR CSCS OP, IGPOP, IGP


IPPE – IIIIPPE – III II SGDSGD ??

Clinical RotationClinical Rotation R, ER, E SGD, OSGD, O OP, DOP, D

3535


3.2.3 – Provide information regarding the documented uses, adverse effects 3.2.3 – Provide information regarding the documented uses, adverse effects and toxicities of dietary supplements.and toxicities of dietary supplements.



Pharmacy Pharmacy PracticePractice

EE CSCS RP, OP, IGPRP, OP, IGP


IPPE – IIIIPPE – III II SGDSGD ??

Clinical RotationClinical Rotation R, ER, E SGD, CS, OSGD, CS, O OP, IGP, DOP, IGP, D

3636


3.2.4 – Provide information regarding the selection, use and care of 3.2.4 – Provide information regarding the selection, use and care of medical/surgical appliances and devices, self-care products, and durable medical/surgical appliances and devices, self-care products, and durable medical equipment, as well as products and techniques for self-monitoring of medical equipment, as well as products and techniques for self-monitoring of health status and medical conditions.health status and medical conditions.




Clinical RotationClinical Rotation R, ER, E SGD, OSGD, O OP, DOP, D

xavier university of louisiana college of pharmacy curriculum map – naplex competencies

Documents